105. Roberts, P.J. and C.J. Der, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 2007. 26(22): p. 3291-310.
106. Chambard, J.C., et al., ERK implication in cell cycle regulation. Biochim Biophys Acta, 2007. 1773(8): p. 1299-310.
107. Mebratu, Y. and Y. Tesfaigzi, How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle, 2009. 8(8): p. 1168-75.
108. Pages, G., et al., Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A, 1993. 90(18): p. 8319-23.
109. Squires, M.S., P.M. Nixon, and S.J. Cook, Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem J, 2002. 366(Pt 2): p. 673-80.
110. Sherr, C.J., Mammalian G1 cyclins. Cell, 1993. 73(6): p. 1059-65.
111. Ortega, S., M. Malumbres, and M. Barbacid, Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta, 2002. 1602(1): p. 73-87.
112. Ohtsubo, M. and J.M. Roberts, Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 1993. 259(5103): p. 1908-12.
113. Diehl, J.A., et al., Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev, 1998. 12(22): p. 3499-511.
114. Zou, Y., et al., Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J Biol Chem, 2004. 279(26): p. 27790-8.
115. Musgrove, E.A., et al., Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci U S A, 1994. 91(17): p. 8022-6.
116. Blomberg, I. and I. Hoffmann, Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol, 1999. 19(9): p. 6183-94.
117. Hsu, J.Y., et al., E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat Cell Biol, 2002. 4(5): p. 358-66.
118. Bell, S.P. and A. Dutta, DNA replication in eukaryotic cells. Annu Rev Biochem, 2002. 71: p. 333-74.
119. Diffley, J.F., Regulation of early events in chromosome replication. Curr Biol, 2004. 14(18): p. R778-86.
120. Groth, A., et al., Chromatin challenges during DNA replication and repair. Cell, 2007. 128(4): p. 721-33.
121. Pines, J. and T. Hunter, Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell, 1989. 58(5): p. 833-46.
122. Ito, M., Factors controlling cyclin B expression. Plant Mol Biol, 2000. 43(5-6): p. 677-90.
123. Trembley, J.H., et al., Genomic organization and promoter characterization of the rat cyclin B1 gene. Gene, 2000. 255(1): p. 93-104.
124. Kakino, S., et al., Intracellular localization of cyclin B1 during the cell cycle in glioma cells. Cytometry, 1996. 24(1): p. 49-54.
125. Lukas, C., et al., Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature, 1999. 401(6755): p. 815-8.
126. Li, J., A.N. Meyer, and D.J. Donoghue, Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc Natl Acad Sci U S A, 1997. 94(2): p. 502-7.
127. Walsh, S., S.S. Margolis, and S. Kornbluth, Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol Cancer Res, 2003. 1(4): p. 280-9.
128. Yang, J., et al., Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev, 1998. 12(14): p. 2131-43.
129. Solomon, M.J., T. Lee, and M.W. Kirschner, Role of phosphorylation in p34cdc2 activation: identification of an activating kinase. Mol Biol Cell, 1992. 3(1): p. 13-27.
130. Sebastian, B., A. Kakizuka, and T. Hunter, Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A, 1993. 90(8): p. 3521-4.
131. Krek, W. and E.A. Nigg, Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. EMBO J, 1991. 10(2): p. 305-16.
132. Palmer, A., A.C. Gavin, and A.R. Nebreda, A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1. EMBO J, 1998. 17(17): p. 5037-47.
133. Strausfeld, U., et al., Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature, 1991. 351(6323): p. 242-5.
134. Honda, R., et al., Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase. FEBS Lett, 1993. 318(3): p. 331-4.
135. Graves, P.R., et al., The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem, 2000. 275(8): p. 5600-5.
136. Peng, C.Y., et al., C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ, 1998. 9(3): p. 197-208.
137. Matsuoka, S., M. Huang, and S.J. Elledge, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 1998. 282(5395): p. 1893-7.
138. Peng, C.Y., et al., Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 1997. 277(5331): p. 1501-5.
139. Dalal, S.N., et al., Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol, 1999. 19(6): p. 4465-79.
140. Sanchez, Y., et al., Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 1997. 277(5331): p. 1497-501.
141. Furnari, B., N. Rhind, and P. Russell, Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science, 1997. 277(5331): p. 1495-7.
142. Foley, E.A. and T.M. Kapoor, Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat Rev Mol Cell Biol, 2013. 14(1): p. 25-37.
143. Rapkine, L., Sur les processus chimiques au cours de la division cellulaire. Ann. Physiol. Physicochim. Biol. , 1931. 7: p. 382-418.
144. Kawamura, N., Cytochemical and quantitative study of protein-bound sulfhydryl and disulfide groups in eggs of Arbacia during the first cleavage. Exp Cell Res, 1960. 20: p. 127-38.
145. Mauro, F., A. Grasso, and L.J. Tolmach, Variations in sulfhydryl, disulfide, and protein content during synchronous and asynchronous growth of HeLa cells. Biophys J, 1969. 9(11): p. 1377-97.
146. Tu, B.P., et al., Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Science, 2005. 310(5751): p. 1152-8.
147. Jonas, C.R., et al., Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic Biol Med, 2002. 33(11): p. 1499-506.
148. Li, N. and T.D. Oberley, Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J Cell Physiol, 1998. 177(1): p. 148-60.
149. Conour, J.E., W.V. Graham, and H.R. Gaskins, A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression. Physiol Genomics, 2004. 18(2): p. 196-205.
150. Oberley, T.D., et al., Antioxidant enzyme levels as a function of growth state in cell culture. Free Radic Biol Med, 1995. 19(1): p. 53-65.
151. Sarsour, E.H., A.L. Kalen, and P. Goswami, Manganese superoxide dismutase regulates a redox cycle within the cell cycle. Antioxid Redox Signal, 2013.
152. Sarsour, E.H., et al., Redox control of the cell cycle in health and disease. Antioxid Redox Signal, 2009. 11(12): p. 2985-3011.
153. Bae, Y.S., et al., Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem, 1997. 272(1): p. 217-21.
154. Sundaresan, M., et al., Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 1995. 270(5234): p. 296-9.
155. DeYulia, G.J., Jr., et al., Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc Natl Acad Sci U S A, 2005. 102(14): p. 5044-9.
156. Krieger-Brauer, H.I. and H. Kather, Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. Biochem J, 1995. 307 ( Pt 2): p. 549-56.
157. Rhee, S.G., Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med, 1999. 31(2): p. 53-9.
158. Chu, C.T., et al., Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem, 2004. 271(11): p. 2060-6.
159. Nishida, M., et al., Activation mechanism of Gi and Go by reactive oxygen species. J Biol Chem, 2002. 277(11): p. 9036-42.
160. Li, F., et al., Superoxide mediates direct current electric field-induced directional migration of glioma cells through the activation of AKT and ERK. PLoS One, 2013. 8(4): p. e61195.
161. Sun, Y. and L.W. Oberley, Redox regulation of transcriptional activators. Free Radic Biol Med, 1996. 21(3): p. 335-48.
162. Cho, Y., et al., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 1994. 265(5170): p. 346-55.
163. Rainwater, R., et al., Role of cysteine residues in regulation of p53 function. Mol Cell Biol, 1995. 15(7): p. 3892-903.
164. Toledano, M.B. and W.J. Leonard, Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A, 1991. 88(10): p. 4328-32.
165. Abate, C., et al., Redox regulation of fos and jun DNA-binding activity in vitro. Science, 1990. 249(4973): p. 1157-61.
166. Burch, P.M. and N.H. Heintz, Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid Redox Signal, 2005. 7(5-6): p. 741-51.
167. Klatt, P., et al., Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J, 1999. 13(12): p. 1481-90.
168. Bergholtz, S., et al., The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties. Nucleic Acids Res, 2001. 29(17): p. 3546-56.
169. Nakshatri, H., P. Bhat-Nakshatri, and R.A. Currie, Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Chem, 1996. 271(46): p. 28784-91.
170. Menon, S.G., et al., Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res, 2003. 63(9): p. 2109-17.
171. Onumah, O.E., et al., Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells. Free Radic Biol Med, 2009. 46(12): p. 1658-67.
172. Wang, H.P., et al., Phospholipid hydroperoxide glutathione peroxidase induces a delay in G1 of the cell cycle. Free Radic Res, 2003. 37(6): p. 621-30.
173. Martinez Munoz, C., et al., The effect of hydrogen peroxide on the cyclin D expression in fibroblasts. Cell Mol Life Sci, 2001. 58(7): p. 990-6.
174. Yamauchi, A. and E.T. Bloom, Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood, 1997. 89(11): p. 4092-9.
175. Menon, S.G., et al., Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res, 2007. 67(13): p. 6392-9.
176. Havens, C.G., et al., Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol, 2006. 26(12): p. 4701-11.
177. Savitsky, P.A. and T. Finkel, Redox regulation of Cdc25C. J Biol Chem, 2002. 277(23): p. 20535-40.
178. Sohn, J. and J. Rudolph, Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry, 2003. 42(34): p. 10060-70.
179. Chang, T.S., et al., Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J Biol Chem, 2002. 277(28): p. 25370-6.
180. Kalen, A.L., et al., Mn-superoxide dismutase overexpression enhances G2 accumulation and radioresistance in human oral squamous carcinoma cells. Antioxid Redox Signal, 2006. 8(7-8): p. 1273-81.
181. Thomas, C.G., et al., Vitamin C transiently arrests cancer cell cycle progression in S phase and G2/M boundary by modulating the kinetics of activation and the subcellular localization of Cdc25C phosphatase. J Cell Physiol, 2005. 205(2): p. 310-8.
182. Obin, M., et al., Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J, 1998. 12(7): p. 561-9.
183. Demasi, M., G.M. Silva, and L.E. Netto, 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem, 2003. 278(1): p. 679-85.
184. Li, Y.P., et al., Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol, 2003. 285(4): p. C806-12.
185. Galperin, M.Y. and E.V. Koonin, A diverse superfamily of enzymes with ATP-dependent carboxylate-amine/thiol ligase activity. Protein Sci, 1997. 6(12): p. 2639-43.
186. Bauer, K., et al., Characterization and biosynthesis of omega-aminoacyl amino acids from rat brain and the C-6 glioma cell line. J Biol Chem, 1979. 254(14): p. 6402-7.
187. Bauer, K., et al., Biosynthesis of carnosine and related peptides by glial cells in primary culture. J Biol Chem, 1982. 257(7): p. 3593-7.
188. Schulz, M., et al., Peptide uptake by astroglia-rich brain cultures. J Neurochem, 1987. 49(3): p. 748-55.
189. Hoffmann, A.M., A. Bakardjiev, and K. Bauer, Carnosine-synthesis in cultures of rat glial cells is restricted to oligodendrocytes and carnosine uptake to astrocytes. Neurosci Lett, 1996. 215(1): p. 29-32.
190. Biffo, S., M. Grillo, and F.L. Margolis, Cellular localization of carnosine-like and anserine-like immunoreactivities in rodent and avian central nervous system. Neuroscience, 1990. 35(3): p. 637-51.
191. Bakardjiev, A. and K. Bauer, Transport of beta-alanine and biosynthesis of carnosine by skeletal muscle cells in primary culture. Eur J Biochem, 1994. 225(2): p. 617-23.
192. Bauer, K. and M. Schulz, Biosynthesis of carnosine and related peptides by skeletal muscle cells in primary culture. Eur J Biochem, 1994. 219(1-2): p. 43-7.
193. Perry, T.L., S. Hansen, and D.L. Love, Serum-carnosinase deficiency in carnosinaemia. Lancet, 1968. 1(7554): p. 1229-30.
194. Lenney, J.F., et al., Characterization of human tissue carnosinase. Biochem J, 1985. 228(3): p. 653-60.
195. Lenney, J.F., et al., Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta, 1982. 123(3): p. 221-31.
196. Bando, K., et al., Fluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathy. Ann Clin Biochem, 1984. 21 ( Pt 6): p. 510-4.
197. Perry, T.L., et al., Homocarnosine in human cerebrospinal fluid: an age-dependent phenomenon. J Neurochem, 1968. 15(10): p. 1203-6.
198. Sobue, K., H. Konishi, and T. Nakajima, Isolation and identification of N-acetylhomocarnosine and N-acetylcarnosine from brain and muscle. J Neurochem, 1975. 24(6): p. 1261-2.
199. Kish, S.J., T.L. Perry, and S. Hansen, Regional distribution of homocarnosine, homocarnosine-carnosine synthetase and homocarnosinase in human brain. J Neurochem, 1979. 32(6): p. 1629-36.
200. Crush, K.G., Carnosine and related substances in animal tissues. Comp Biochem Physiol, 1970. 34(1): p. 3-30.
201. I.R., M., Enzymatic synthesis of anserine in skeletal muscle by N-methylation of carnosine. The Journal of Biological Chemistry 1962. 237: p. 1207-1211.
202. Jackson, M.C., C.M. Kucera, and J.F. Lenney, Purification and properties of human serum carnosinase. Clin Chim Acta, 1991. 196(2-3): p. 193-205.
203. ChemSpider Free chemical structure database, www.chemspider.com
204. Brown, C.E. and W.E. Antholine, Multiple forms of the cobalt(II)-carnosine complex. Biochem Biophys Res Commun, 1979. 88(2): p. 529-36.
205. Viola, R.E., C.R. Hartzell, and J.J. Villafranca, Copper(II) complexes of carnosine, glycylglycine, and glycylglycine-imidazole mixtures. Journal of Inorganic Biochemistry, 1979. 10(4): p. 293-307.
206. Aruoma, O.I., M.J. Laughton, and B. Halliwell, Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem J, 1989. 264(3): p. 863-9.
207. Kang, J.H., Protective effects of carnosine and homocarnosine on ferritin and hydrogen peroxide-mediated DNA damage. BMB Rep, 2010. 43(10): p. 683-7.
208. Renner, C., Seyffarth, A., Garcia de Arriba, S., Meixensberger, J., Gebhardt, R., Gaunitz, F., Carnosine Inhibits Growth of Cells Isolated from Human Glioblastoma Multiforme. International Journal of Peptide Research and Therapeutics 2008. 14: p. 127-135.
209. Iovine, B., et al., Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production. Cancer Lett, 2012. 315(2): p. 122-8.
210. Rybakova, Y.S. and A.A. Boldyrev, Effect of Carnosine and Related Compounds on Proliferation of Cultured Rat Pheochromocytoma PC-12 Cells. Bulletin of Experimental Biology and Medicine, 2012. 154(1): p. 136-140.
211. Dahl, T.A., W.R. Midden, and P.E. Hartman, SOME PREVALENT BIOMOLECULES AS DEFENSES AGAINST SINGLET OXYGEN DAMAGE. Photochemistry and Photobiology, 1988. 47(3): p. 357-362.
212. Hartman, P.E., Z. Hartman, and K.T. Ault, Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol, 1990. 51(1): p. 59-66.
213. Швачко, А.Г., Формазюк, В.Е., Сергиенко В.И., Тушение хемилюминесценции синглетного кислорода в присутствии карнозина. 1990: p. 155-156.
214. Brawn, K. and I. Fridovich, DNA strand scission by enzymically generated oxygen radicals. Arch Biochem Biophys, 1981. 206(2): p. 414-9.
215. Klebanov, G.I., et al., Effect of carnosine and its components on free-radical reactions. Membr Cell Biol, 1998. 12(1): p. 89-99.
216. RUBTSOV, A., et al., HYDROXYL RADICAL-SCAVENGING ACTIVITY OF CARNOSINE - A SPIN TRAPPING STUDY. Acta Pharmaceutica Jugoslavika, 1991. 41(4): p. 401-407.
217. Poli, G. and R.J. Schaur, 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life, 2000. 50(4-5): p. 315-21.
218. Северин С. Е., Б.А.А., Стволинский С. Л., Бордюков, М.М., Гончаренко, Е.Н., Деев, Л.И., Малинина, И.Е., Кудряшов, Ю.Е. , О радиомодифицирующих свойствах карнозина. Радиобиология, 1990. 30(6): p. 765-768.
219. Курелла, Е.Г., Мальцева, В. В., Сеславина, С. Л., Стволинский, С. Л., Стимулирующее действие карнозина на гемопоэтические стволовые клетки. Бюл. эксп. биол. мед, 1991. 7: p. 52-53.
220. Мальцева, В.В., Сергиенко, В. И., Стволинский, С.Л., Влияние карнозина на активность гемопоэтических стволовых клеток у облученных животных. Биохимия, 1992. 57(9): p. 1378-1382.
221. Hayflick, L., THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res, 1965. 37: p. 614-36.
222. McFarland, G.A. and R. Holliday, Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol, 1999. 34(1): p. 35-45.
223. Shao, L., Q.H. Li, and Z. Tan, L-carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts. Biochem Biophys Res Commun, 2004. 324(2): p. 931-6.
224. Levy, M.Z., et al., Telomere end-replication problem and cell aging. J Mol Biol, 1992. 225(4): p. 951-60.
225. Renner, C., et al., Carnosine inhibits ATP production in cells from malignant glioma. Neurol Res, 2010. 32(1): p. 101-5.
226. McFarland, G. and R. Holliday, Differential response of embryonic stem cells and teratocarcinoma cells to carnosine. In Vitro Cell Dev Biol Anim, 1999. 35(1): p. 15-6.
227. Asperger, A., et al., Identification of factors involved in the anti-tumor activity of carnosine on glioblastomas using a proteomics approach. Cancer Invest, 2011. 29(4): p. 272-81.
228. Tsuchiya, H., T. Iseda, and O. Hino, Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res, 1996. 56(13): p. 2881-5.
229. Luo, W., et al., Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem, 2010. 285(6): p. 3651-63.
230. Hohfeld, J. and S. Jentsch, GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J, 1997. 16(20): p. 6209-16.
231. Borges, J.C., et al., Free human mitochondrial GrpE is a symmetric dimer in solution. J Biol Chem, 2003. 278(37): p. 35337-44.
232. Graner, M.W., et al., Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Sci, 2009. 100(10): p. 1870-9.
233. Kizaka-Kondoh, S., et al., The HIF-1-active microenvironment: an environmental target for cancer therapy. Adv Drug Deliv Rev, 2009. 61(7-8): p. 623-32.
234. Rybakova, Y., et al., Receptor-mediated oxidative stress in murine cerebellar neurons is accompanied by phosphorylation of MAP (ERK 1/2) kinase. Curr Aging Sci, 2012. 5(3): p. 225-30.